Skip to main content

Table 3 Differences in co-morbidity amongst normal weight (BMI 18.5 to < 25.0 kg/m2) and obese (BMI > 35 kg/m2) participants that tested positive for Covid-19

From: Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank

  Normal weight (BMI18- < 25 kg/m2) Obese (BMI > 35 kg/m2) Odds ratio (95% CI) P
Number (n) 389 204
Age (mean years ± SD) 67 ± 9 68 ± 9 0.20
Hypertension (n) 84 119 5.08 (3.53–7.30) < 0.0001
Dyslipidaemia (n) 42 64 3.78 (2.44–5.84) < 0.0001
Atrial fibrillation (n) 24 29 2.52 (1.46–4.48) 0.0021
Ventricular arrhythmia (n) 5 1 0.38 (0.032–2.76) 0.67
Diabetes (n) 15 67 12.19 (6.71–22.19) < 0.0001
Stroke (n) 6 5 1.60 (0.55–5.47) 0.52
Angina (n) 20 38 4.22 (2.40–7.38) < 0.0001
  1. Amongst those testing positive for Covid-19, participants with BMI > 35 kg/m2 (obese II) have greater odds ratios for hypertension, dyslipidaemia, atrial fibrillation, diabetes and angina than individuals with normal weight (BMI 18.5 to < 25.0 kg/m2). There were no differences between groups for stroke and ventricular arrhythmia. T test was used to test for differences in age between groups, and Fisher’s exact test for categorical variables